For 19 scientists in Belgium and The Netherlands, good news arrived just in time for the summer holidays as they were granted an ERC Proof of Concept grant. Among them are four KNCV-/NVBMB-members.
The €150,000 ERC Proof of Concepts grant facilitate the initial steps from basic research results to a potential application, i.e. to develop a proof-of-concept. Only proposals that built on results stemming from previous ERC-funded projects are eligible for a PoC grant. With the PoC grants, the ERC enables researchers to explore the opportunities their initial results offer, for example through further validation studies or an assessment of intellectual property potential. A total of 100 proposals were honoured with a PoC grant, including these four that were submitted by KNCV-members:
Kim Bonger, Leiden University
THRON-SEC: Drug-induced secretome profiling for enhanced therapy
Tom de Greef, Eindhoven University of Technology
DNACryp: DNA encryption of compartmentalized DNA files
Nathaniel Martin, Leiden University
PREVAIL: PReclinical EVAluation and Investigation of Laterocidamide - A novel antibiotic from a new drug class to overcome polymyxin resistance
Sander van Kasteren (also NVBMB-member), Leiden University
TIGER: Targeted immunocytokines by caging and local release
Other chemistry and life sciences-related laureates based at an institution in Belgium or The Netherlands (in alphabetical order)
Rob Ameloot, KU Leuven
MOFKADD: Metal-organic-framework kinetic array for diabetes detection
Ruben van Boxtel, Princess Maxima Centre for Pediatric Oncologie
MUTAPREDICT: Benchmarking AI to predict mutagenicity by combining chemical structure and genome-wide mutation data
Susana Chuva de Sousa Lopes, Leiden University Medical Center
ReproTox: Developing a human-based stem cell model for reproductive toxicity
David Fernandez Rivas, University of Twente
Lab-in-skin: Overcoming limits for preclinical small volume liquid delivery into skin and inflammation quantification
Sabine Fuchs, University Medical Center Utrecht
IMPACT: IMPlementation of Affordable gene Correction Therapies
Jop Kind, Hubrecht Institute (KNAW)
OncoID: Deep multiplexed epigenetic profiling of plasma cell-free nucleosomes for early cancer diagnostics
Bart Lambrecht, Flanders Institute for Biotechnology
CRYSTAL-SHINE: A nanobody imaging tool to detect protein crystals and predict therapeutic response in asthmatics
Jeroen Leijten, University of Twente
NutriBone: Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles
Isabelle Meyts, KU Leuven
MODULATEDADA2: Towards modulator therapy for ADA2 deficiency
Robert de Vries, Utrecht University
Arrayed surveillance: Glycoprotein arrays for functional virus surveillance
Overview of awarded Proof of Concept grants 2024 on the ERC website
Nog geen opmerkingen